Main Menu

Cancer Biomarkers Team

Professor Johann de Bono’s team conducts biomarker-driven clinical and translational research to accelerate the development of novel cancer therapies and improve understanding of cancer biology, drug sensitivity and resistance.

Group leader

Professor Johann De Bono

Professor Johann De Bono

Divisional Head of Clinical Studies

Professor Johann de Bono is the Head of the Division of Clinical Studies and an international expert in the development of novel anticancer therapies against adult cancers. His team of runs one of the world’s largest phase I clinical trials units for cancer, with >100 staff including dedicated radiology and pathology staff; he also runs a separate team focused on improving prostate cancer care that have led pivotal phase III trials of several prostate cancer drugs including abiraterone, cabazitaxel, enzalutamide and olaparib as well more recently ipatasertib and lutetium-PSMA.

ORCID 0000-0002-2034-595X

Group members

Yasmin Ball

Scientific Officer +44 20 3437 6198

Ilona Bernett

Higher Scientific Officer +44 20 3437 6542

Claudia Bertan

Higher Scientific Officer +44 20 3437 6460

Denisa Bogdan

Bioinfomatician +44 20 3437 6096

Lorenzo Buroni

Higher Scientific Officer +44 20 3437 6665

Mateus Crespo

Senior Scientific Officer +44 20 3437 6336

Berni Ebbs

Higher Scientific Officer +44 20 8915 4343

Ana Ferreira

Higher Scientific Officer +44 20 3437 6319

Ines Figueiredo

Senior Scientific Officer +44 20 3437 6318

Penny Flohr

Senior Scientific Officer +44 20 8915 4038

Jane Goodall

Senior Scientific Officer +44 20 3437 6323

Dr Bora Gurel

Clinical Scientist +44 20 8722 4567

Susana Miranda

Higher Scientific Officer +44 20 3437 6316

Helder Ramos

Clinical Data Manager +44 20 3437 6065

Rita Santos

Higher Scientific Officer +44 20 3437 6972

Dr George Seed

+44 20 3437 6063

Franziska Weigl

PhD Student +44 20 3437 6058

Franziska Weigl

PhD Student +44 20 3437 6058